Suggestions

Du même auteur

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Archive ouverte | Wang, Michael | CCSD

IF 53.254 (2017). International audience. BACKGROUND:Bruton tyrosine kinase is a clinically validated target in mantle cell lymphoma. Acalabrutinib (ACP-196) is a highly selective, potent Bruton tyrosine kinase inhi...

Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

Archive ouverte | Wang, Michael | CCSD

International audience. No abstract available

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Archive ouverte | Kastritis, Efstathios | CCSD

International audience

Chargement des enrichissements...